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Keratins and keratin-associated proteins (KAPs) constitute the major structural protein 
components of the hair. Regulation of their expression is critical for proper hair follicle (HF) 
structure and function [1]. Therefore, it is important to fully elucidate the controls that 
regulate keratin expression. Although it is accepted that the expression of selected keratin 
genes underlies endocrine controls [1,2], our understanding of the complex regulation of 
keratin expression remains rather fragmentary. To better elucidate this regulation, human skin 
and HF organ culture offer an instructive, physiologically relevant research tool [1,3].  
 
In particular, very little is known on the neuroendocrine controls of keratin transcription. The 
importance of the latter is highlighted by the recent discovery that the "pituitary" neuropeptide 
hormone, prolactin, which is also expressed by human HFs, potently regulates the expression 
of selected human keratins on the gene and protein level [3]. Moreover, microarray analyses 
had provided first clues that thyroid stimulating hormone (TSH) and its proximal regulator in 
the hypothalamic-pituitary-thyroid axis, thyrotropin-releasing hormone (TRH), might operate 
as previously unsuspected modulators of human hair keratin and KAP gene transcription in 
situ [4-6]. Also, we had recently found that TSH upregulates keratin K5 gene expression and 
protein synthesis as well as K14 transcription in human epidermis [4].  
 
Therefore, we have asked whether TSH operates as a novel neuroendocrine regulator of 
human keratins in situ, using microdissected, organ-cultured human scalp HFs as a 
physiologically and clinically relevant assay systems [3-5]. This was complemented by 
studying the effect of TSH on keratin expression in cultured human outer root sheath (ORS) 
keratinocytes (KCs). 
 
Anagen VI HFs were isolated from normal frontotemporal scalp skin obtained after written 
informed consent from three healthy females undergoing routine face-lift surgery, as 
  
3 
previously described [4,5], adhering to Helsinki guidelines and under a licence from the ethics 
committee of the University of Lübeck. HF mRNA extracts from one female patient were 
subjected to quantitative real time PCR (qPCR) for selected hair keratin genes after 24 hrs 
treatment with TSH (100 mU ml
-1
) or vehicle. For immunohistochemical analysis, isolated 
HFs from additional two female patients were organ cultured for 6 days as described 
previously [3,4], and expression of keratins K6, K14, K17, K31, K32, K85 and MSX-2 was 
studied with our previously published basic immunohistology protocols [3,4] (Table 1). For 
epithelial keratin qPCR experiments, human ORS KCs were obtained from an additional 
female patient, as previously described [3]. These were treated for 24h with TSH (100 mU ml
-
1
) or vehicle.  
 
Our previous microarray results had suggested that TSH administration significantly 
downregulates expression of K31 [4], thus suggesting a role for TSH in the regulation of hair 
keratins. To further explore this microarray lead, we performed qPCR on carefully selected 
hair keratins that are expressed in the hair shaft-generating HF epithelium, representing three 
major compartments of the HF epithelium: the hair matrix/precortex and cuticle (K35), the 
hair cortex (K31) and the hair cuticle (K32) [2]. Particular emphasis was placed on studying 
KRT85 and KRT35 transcription, since both keratins are the earliest ones to be expressed in 
the precortical hair matrix and early cuticle [2].  
 
These qPCR analyses demonstrated that TSH downregulated transcription of KRT31 and 
KRT32 genes (Fig. 1A). In these qPCR analyses, KRT35 transcription was largely unaffected 
by TSH. Instead, transcription of its type II counterpart keratin gene, KRT85 [2], was 
downregulated (Fig. 1A).  
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Immunohistochemical studies on TSH treated HFs confirmed the downregulation of the hair 
keratins also at the protein level (Fig. 2A-C): K31 immunoreactivity, localized to the hair 
cortex (Fig. 2A), K85 immunoreactivity, which is expressed in the hair cortex and in the 
precortical hair matrix (Fig. 2B) and K32 immunoreactivity, which serves as a marker for the 
hair cuticle (Fig. 2C), were significantly downregulated following TSH administration. Since 
MSX2 serves as a major transcription factor that regulates hair keratin expression [7], analysis 
of MSX2 expression was also performed. Indeed, TSH downregulated MSX2 transcription in 
human anagen HFs in situ (Fig. 1A). MSX2 immunoreactivity was found to correspond to the 
expression pattern in the mouse, the hair matrix and cortex (Fig. 2D) [8]. In line with the 
qPCR results, TSH downregulated MSX2 immunoreactivity (Fig. 2D).    
 
Several epithelial keratins are widely expressed in the HF ORS, where they are thought to 
play an important role in maintaining structural integrity and homeostasis [1]. We have 
previously confirmed that TSH has a regulatory effect on K5 [4], which is prominently 
expressed in the ORS [1]. We have therefore further explored this finding, by studying the 
effects of TSH on selected epithelial keratins which are constitutively expressed in the ORS 
[2]. HF treatment with TSH significantly downregulated K6, K14 and K17 immunoreactivity 
(Fig. 2E-G). In order to confirm these findings in isolated HF KCs in situ, TSH treated ORS 
KCs were analyzed by qPCR. This showed a significant downregulation of KRT6 and KRT17 
transcription, but no effect on KRT14 transcription (Fig. 1B). 
 
Exploiting the human HF as a discovery tool for keratin research, the current pilot study 
identifies TSH as a novel neuroendocrine regulator of keratin expression in human skin. The 
data provided here also suggest that the hair shaft abnormalities seen in patients with hyper- 
or hypothyroidism [9] may result not only from perturbations in the thyroid hormone blood 
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levels, but also from associated neuroendocrine changes in TSH levels in the blood, or even in 
the skin [6,10]. 
 
The regulation of hair keratin gene expression is tightly controlled by a complex mechanism 
involving several upstream mediators. These include members of the Wnt/β-catenin pathway 
and of the TGF-β family which control MSX2, FOXN1 and HOXC13 activity [1,2,7,11,12]. 
Since MSX2 is a major regulator of hair shaft differentiation, our observation that TSH 
reduces MSX2 expression on the gene and protein level encourages one to pursue the 
hypothesis that TSH may act at least in part via inhibiting MSX2 expression. 
 
While KRT35 transcription was not inhibited by TSH, TSH downregulated KRT85 
expression. Such a unilateral keratin regulation has been documented before for the cuticle 
keratin K82 [13]. It is conceivable that the TSH-induced upregulation of KAPs transcription 
previously observed by microarray analysis [4] may compensate for the downregulation of 
one type of keratin, as an attempt to maintain structural stability of the hair shaft.  
 
In summary, our pilot study reveals that the expression of selected HF keratins underlies 
novel neuroendocrine controls, possibly as part of the unfolding hypothalamus-pituitary-
thyroid axis equivalent present in human skin [4-6,10]. As shown for prolactin [3] and TSH, 
human HF organ culture offers an excellent research tool to further dissect ”novel” 
neuroendocrine in situ-controls that drive keratin expression in the human system under 
clinically relevant conditions on the gene and protein level.  
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Figure legends 
 
Fig 1. A. Relative mRNA expression of KRT35, KRT31, KRT32, KRT85 and MSX2 genes 
following treatment with TSH (100 mU ml
-1
). This dose was selected since it is within the 
range of customarily employed TSH concentrations in cell culture studies, and because this 
dose has been previously shown by microarray analysis to regulate the expression of several 
genes in organ-cultured human hair follicles [4]. Results represent triplicate determinations of 
samples. Total RNA was pooled from 20 HFs. B. Relative mRNA expression of KRT6, 
KRT14 and KRT17 following administration of TSH to ORS KCs in culture, extracted from 
HFs of an additional female patient. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001; mean ± SEM. PCR 
amplification was carried out by using the TaqMan primers and probes (recognizing the 
following human genes: Assay ID: Hs01699178_gH for KRT6, Assay ID: Hs00265033_m1 
for KRT14, Assay ID: Hs00356958_m1 for KRT17, Assay ID: Hs00605539_m1 for KRT31, 
Assay ID: Hs00605543_g1 for KRT32, Assay ID: Hs00605557_g1 for KRT35, Assay ID: 
Hs00158558_m1 for KRT85, Assay ID: Hs00741177_m1 for MSX2) using the TaqMan 
Universal PCR Master Mix Protocol (Applied Biosystems). As internal controls, transcripts of 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were determined (Assay ID: 
Hs99999905_m1 for human GAPDH). 
 
Fig. 2. TSH (100 mU ml
-1
) downregulates immunoreactivity of K31 (A), K85 (B), K32 (C), 
MSX-2 (D), K6 (E), K14 (F) and K17 (G) in microdissected, organ-cultured normal, human 
scalp skin HFs, after 6 days of administration. Densitometric measurements of staining 
intensities in defined reference areas (quantitative immunohistomorphometry) were 
performed using ImageJ software (NIH, Bethesda, MD, USA; http://rsbweb. nih.gov/ij/) as 
described previously [3,4]. Columns represent means±SEM ; n=15–18 HFs/group; cumulative 
results of two different experiments. ***P<0.001. 
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TABLE 1. Primary antibodies used 
 
Name Host Dilution Positive control Method Source Clone 
Keratin 6 Mouse 1:10 
Suprabasal layers of the ORS; suprabasal layers of 
wounded skin [2,14] 
Indirect 
IF 
PROGEN, Heidelberg, Germany Ks6.KA12 
Keratin 
14 
Mouse 1:50 
Skin epidermis, basal layer; basal and 
suprabasal layers of the ORS [2,14] 
Indirect 
IF 
Sigma-Aldrich, Taufkirchen, 
Germany 
CKB1 
Keratin 
17 
Mouse 1:50 Suprabasal layers of the ORS [14] 
Indirect 
IF 
PROGEN, Heidelberg, Germany Ks17.E3 
Keratin 
31 
Guinea 
Pig 
1:7000 Precortex region [2] 
Indirect 
IF 
Lutz Langbein, DKFZ, 
Heidelberg, Germany 
hHa1 
prot.1 
Keratin 
32 
Guinea 
Pig 
1:2000 Hair cuticle [10,14] 
Indirect 
IF 
Lutz Langbein, DKFZ, 
Heidelberg, Germany 
Ha2.1 
Keratin 
85 
Guinea 
Pig 
1:1000 Hair matrix, cortex and cuticle [14] 
Indirect 
IF 
Lutz Langbein, DKFZ, 
Heidelberg, Germany 
hHb 5co.2 
Msx-2 Goat 1:100 Hair matrix and cortex [8] 
Indirect 
IF 
Santacruz, CA, USA - 
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